1. Home
  2. EZPW vs AMLX Comparison

EZPW vs AMLX Comparison

Compare EZPW & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$25.95

Market Cap

1.6B

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$13.76

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
AMLX
Founded
1989
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
EZPW
AMLX
Price
$25.95
$13.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$26.67
$19.56
AVG Volume (30 Days)
769.9K
790.9K
Earning Date
04-27-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
65.46
EPS
0.55
N/A
Revenue
$747,954,000.00
$380,786,000.00
Revenue This Year
$24.85
N/A
Revenue Next Year
$11.13
N/A
P/E Ratio
$47.18
N/A
Revenue Growth
2.39
1612.94
52 Week Low
$12.89
$3.11
52 Week High
$27.30
$17.49

Technical Indicators

Market Signals
Indicator
EZPW
AMLX
Relative Strength Index (RSI) 56.19 45.16
Support Level $24.38 $13.36
Resistance Level $26.35 $15.37
Average True Range (ATR) 0.89 0.90
MACD -0.19 -0.09
Stochastic Oscillator 53.77 10.38

Price Performance

Historical Comparison
EZPW
AMLX

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: